Trial of BMS-986012 in Combination With Platinum and Etoposide

NCT02815592 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: BMS-986012
DRUG: Cisplatin
DRUG: Etoposide
DRUG: Platinum
DRUG: Carboplatin

Sponsor

Bristol-Myers Squibb